LIWANLI Innovation Co., Ltd. (TPE:3054)
Taiwan · Delayed Price · Currency is TWD 63.40
+2.20 (3.59%)
At close: Jul 9, 2026
LIWANLI Innovation Market Cap
LIWANLI Innovation has a market cap or net worth of 5.11 billion as of July 9, 2026. Its market cap has increased by 173.28% in one year.
Market Cap
5.11B
Enterprise Value
4.62B
Revenue
243.15M
Ranking
n/a
PE Ratio
18.94
Stock Price
63.40
Market Cap Chart
Since April 23, 2003, LIWANLI Innovation's market cap has increased from 1.72B to 5.11B, an increase of 196.72%. That is a compound annual growth rate of 4.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 5.11B | 95.38% |
| Dec 31, 2025 | 2.62B | 31.64% |
| Dec 31, 2024 | 1.99B | 17.38% |
| Dec 29, 2023 | 1.69B | 5.26% |
| Dec 30, 2022 | 1.61B | -23.52% |
| Dec 30, 2021 | 2.10B | 5.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alar Pharmaceuticals | 8.62B |
| Formosa Laboratories | 6.75B |
| Orient Pharma | 6.07B |
| Panion & Bf Biotech | 5.57B |
| SCI Pharmtech | 5.35B |
| Easywell Biomedicals | 4.19B |
| Orient EuroPharma | 4.18B |
| Tien Liang BioTech | 3.31B |